|
🐜
|
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
18 auth.
D. Bennett,
R. Camacho,
D. Oțelea,
D. Kuritzkes,
H. Fleury,
M. Kiuchi,
W. Heneine,
R. Kantor,
M. Jordan,
J. Schapiro,
...
A. Vandamme,
P. Sandstrom,
C. Boucher,
D. A. van de Vijver,
Soo-Yon Rhee,
Tommy F. Liu,
D. Pillay,
R. Shafer
|
9 |
2009 |
9
🐜
|
|
🐜
|
Digital technologies in the public-health response to COVID-19
17 auth.
Jobie Budd,
Benjamin S. Miller,
E. M. Manning,
Vasileios Lampos,
Mengdie Zhuang,
M. Edelstein,
G. Rees,
V. Emery,
Molly M. Stevens,
Neil Keegan,
...
Michael Short,
D. Pillay,
E. Manley,
I. Cox,
D. Heymann,
A. Johnson,
R. McKendry
|
9 |
2020 |
9
🐜
|
|
🐜
|
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
16 auth.
A. Banerjee,
L. Pasea,
S. Harris,
A. Gonzalez-Izquierdo,
A. Torralbo,
L. Shallcross,
M. Noursadeghi,
D. Pillay,
N. Sebire,
C. Holmes,
...
C. Pagel,
W. K. Wong,
C. Langenberg,
B. Williams,
S. Denaxas,
H. Hemingway
|
8 |
2020 |
8
🐜
|
|
🐜
|
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
28 auth.
L. Wittkop,
H. Günthard,
F. de Wolf,
D. Dunn,
A. Cozzi-Lepri,
A. De Luca,
C. Kücherer,
N. Obel,
V. von Wyl,
B. Masquelier,
C. Stephan,
C. Torti,
A. Antinori,
Federico García,
A. Judd,
...
K. Porter,
R. Thiébaut,
H. Castro,
A. van Sighem,
Céline Colin,
J. Kjaer,
J. Lundgren,
R. Paredes,
A. Pozniak,
B. Clotet,
A. Phillips,
D. Pillay,
G. Chêne
|
8 |
2011 |
8
🐜
|
|
🐜
|
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
11 auth.
Ravindra K. Gupta,
M. Jordan,
B. Sultan,
A. Hill,
Daniel H. J. Davis,
J. Gregson,
...
A. Sawyer,
R. Hamers,
N. Ndembi,
D. Pillay,
S. Bertagnolio
|
8 |
2012 |
8
🐜
|
|
🐜
|
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
29 auth.
D. Frampton,
Tommy Rampling,
A. Cross,
H. Bailey,
J. Heaney,
Matthew Byott,
R. Scott,
Rebecca Sconza,
J. Price,
M. Margaritis,
M. Bergstrom,
M. Spyer,
Patricia Miralhes,
P. Grant,
S. Kirk,
...
C. Valerio,
Z. Mangera,
Thaventhran Prabhahar,
J. Moreno-Cuesta,
N. Arulkumaran,
M. Singer,
G. Y. Shin,
Emilie Sanchez,
Stavroula M. Paraskevopoulou,
D. Pillay,
R. McKendry,
M. Mirfenderesky,
C. Houlihan,
E. Nastouli
|
8 |
2021 |
8
🐜
|
|
🐜
|
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
8 auth.
R. Shafer,
Soo-Yon Rhee,
D. Pillay,
V. Miller,
P. Sandstrom,
J. Schapiro,
...
D. Kuritzkes,
D. Bennett
|
8 |
2007 |
8
🐜
|
|
🐜
|
Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration
31 auth.
R. Kantor,
D. Katzenstein,
B. Efron,
A. Carvalho,
B. Wynhoven,
P. Cane,
J. Clarke,
S. Sirivichayakul,
M. Soares,
J. Snoeck,
C. Pillay,
H. Rudich,
R. Rodrigues,
Á. Holguín,
K. Ariyoshi,
...
M. B. Bouzas,
P. Cahn,
W. Sugiura,
V. Soriano,
L. Brigido,
Z. Grossman,
L. Morris,
A. Vandamme,
A. Tanuri,
P. Phanuphak,
J. Weber,
D. Pillay,
P. Harrigan,
R. Camacho,
J. Schapiro,
R. Shafer
|
8 |
2005 |
8
🐜
|
|
🐜
|
2011 update of the drug resistance mutations in HIV-1.
8 auth.
V. Johnson,
V. Calvez,
H. Günthard,
R. Paredes,
D. Pillay,
R. Shafer,
...
A. Wensing,
D. Richman
|
8 |
2011 |
8
🐜
|
|
🐜
|
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
224 auth.
P. Mugyenyi,
A. Walker,
J. Hakim,
P. Munderi,
D. Gibb,
C. Kityo,
A. Reid,
H. Grosskurth,
J. Darbyshire,
F. Ssali,
D. Bray,
E. Katabira,
A. Babiker,
C. Gilks,
G. Kabuye,
...
D. Nsibambi,
R. Kasirye,
E. Zalwango,
M. Nakazibwe,
B. Kikaire,
G. Nassuna,
R. Massa,
K. Fadhiru,
M. Namyalo,
A. Zalwango,
L. Generous,
P. Khauka,
N. Rutikarayo,
W. Nakahima,
A. Mugisha,
J. Todd,
J. Levin,
S. Muyingo,
A. Ruberantwari,
P. Kaleebu,
D. Yirrell,
N. Ndembi,
F. Lyagoba,
P. Hughes,
M. Aber,
A. M. Lara,
S. Foster,
J. Amurwon,
B. N. Wakholi,
J. Whitworth,
K. Wangati,
B. Amuron,
D. Kajungu,
J. Nakiyingi,
W. Omony,
D. Tumukunde,
T. Otim,
J. Kabanda,
H. Musana,
J. Akao,
H. Kyomugisha,
A. Byamukama,
J. Sabiiti,
J. Komugyena,
P. Wavamunno,
S. Mukiibi,
A. Drasiku,
R. Byaruhanga,
O. Labeja,
P. Katundu,
S. Tugume,
P. Awio,
A. Namazzi,
G. Bakeinyaga,
H. Katabira,
D. Abaine,
J. Tukamushaba,
W. Anywar,
W. Ojiambo,
E. Angweng,
S. Murungi,
W. Haguma,
S. Atwiine,
J. Kigozi,
L. Namale,
A. Mukose,
G. Mulindwa,
D. Atwiine,
A. Muhwezi,
E. Nimwesiga,
G. Barungi,
J. Takubwa,
D. Mwebesa,
G. Kagina,
M. Mulindwa,
F. Ahimbisibwe,
P. Mwesigwa,
S. Akuma,
C. Zawedde,
D. Nyiraguhirwa,
C. Tumusiime,
L. Bagaya,
W. Namara,
J. Karungi,
R. Kankunda,
R. Enzama,
A. Latif,
V. Robertson,
E. Chidziva,
R. Bulaya-Tembo,
G. Musoro,
F. Taziwa,
C. Chimbetete,
L. Chakonza,
A. Mawora,
C. Muvirimi,
G. Tinago,
P. Svovanapasis,
M. Simango,
O. Chirema,
J. Machingura,
S. Mutsai,
M. Phiri,
T. Bafana,
M. Chirara,
L. Muchabaiwa,
M. Muzambi,
J. Mutowo,
T. Chivhunga,
E. Chigwedere,
M. Pascoe,
C. Warambwa,
E. Zengeza,
F. Mapinge,
S. Makota,
A. Jamu,
N. Ngorima,
H. Chirairo,
S. Chitsungo,
J. Chimanzi,
C. Maweni,
R. Warara,
M. Matongo,
S. Mudzingwa,
M. Jangano,
K. Moyo,
L. Vere,
N. Mdege,
I. Machingura,
A. Ronald,
A. Kambungu,
F. Lutwama,
I. Mambule,
A. Nanfuka,
J. Walusimbi,
E. Nabankema,
R. Nalumenya,
T. Namuli,
R. Kulume,
I. Namata,
L. Nyachwo,
A. Florence,
A. Kusiima,
E. Lubwama,
R. Nairuba,
F. Oketta,
E. Buluma,
R. Waita,
H. Ojiambo,
F. Sadik,
J. Wanyama,
P. Nabongo,
J. Oyugi,
F. Sematala,
A. Muganzi,
C. Twijukye,
H. Byakwaga,
R. Ochai,
D. Muhweezi,
A. Coutinho,
B. Etukoit,
C. Gilks,
K. Boocock,
C. Puddephatt,
C. Grundy,
J. Bohannon,
D. Winogron,
A. Burke,
A. Babiker,
H. Wilkes,
M. Rauchenberger,
S. Sheehan,
C. Spencer-Drake,
K. Taylor,
M. Spyer,
A. Ferrier,
B. Naidoo,
D. Dunn,
R. Goodall,
L. Peto,
R. Nanfuka,
C. Mufuka-Kapuya,
D. Pillay,
A. McCormick,
I. Weller,
S. Bahendeka,
M. Bassett,
A. Wapakhabulo,
B. Gazzard,
C. Mapuchere,
O. Mugurungi,
C. Burke,
S. Jones,
C. Newland,
G. Pearce,
S. Rahim,
J. Rooney,
M. Smith,
W. Snowden,
J. Steens,
A. Breckenridge,
A. Mclaren,
C. Hill,
J. Matenga,
A. Pozniak,
D. Serwadda,
T. Peto,
A. Palfreeman,
M. Borok
|
8 |
2010 |
8
🐜
|
|
🐜
|
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
33 auth.
Ravindra K. Gupta,
J. Gregson,
N. Parkin,
H. Haile-Selassie,
A. Tanuri,
Liliana Andrade Forero,
P. Kaleebu,
C. Watera,
A. Aghokeng,
N. Mutenda,
J. Dzangare,
S. Hone,
Zaw Zaw Hang,
Judith Garcia,
Zully Garcia,
...
P. Marchorro,
E. Beteta,
Amalia Girón,
R. Hamers,
S. Inzaule,
L. Frenkel,
M. Chung,
Túlio de Oliveira,
D. Pillay,
K. Naidoo,
A. Kharsany,
R. Kugathasan,
T. Cutiño,
G. Hunt,
S. Avila Rios,
M. Doherty,
M. Jordan,
S. Bertagnolio
|
8 |
2017 |
8
🐜
|
|
🐜
|
Update of the drug resistance mutations in HIV-1: Fall 2006.
7 auth.
V. Johnson,
F. Brun-vezinet,
B. Clotet,
D. Kuritzkes,
D. Pillay,
J. Schapiro,
...
D. Richman
|
8 |
2006 |
8
🐜
|
